June 2026– date –
-
Cambridge University & GlitterinTech Develop $10 Spectrometer Chip Delivering Lab-Grade Chemical Analysis for Non-Invasive Wearable Biomarker Monitoring
Rasayanika UK Overview Researchers from Cambridge University and GlitterinTech have developed a compact spectrometer chip costing approximately $10, capable of lab-grade chemical analysis. This centimeter-scale chip holds the potential f... -
UNSW Researchers Develop Tiny Wearable Auscultation Sensor for Home Monitoring of Cardiac and Respiratory Conditions
Quicknews Australia Overview Researchers at UNSW have developed a small, flexible wearable auscultation sensor designed to enable continuous home monitoring for individuals with cardiac and respiratory conditions. This sensor patch effic... -
Diabetes Devices Dominate FDA MAUDE Reports 2020-2025 with Over 50% of Adverse Events, Dexcom Largest Single Reporter
Global MedTech Expert | 10× MedTech Global Access Unknown Overview An analysis of 14.4 million FDA MAUDE adverse event reports from 2020 to 2025 reveals that diabetes-related devices account for over half of all reported events. Continuo... -
Supply Chain Integrity Under Fire: Pharmsource Denies Knowledge of Stolen, Recalled Dexcom G7 Sensors
Investing.com 南アフリカ Overview Pharmaceutical wholesaler Pharmsource LLC denies knowing that Dexcom G7 continuous glucose monitoring (CGM) sensors it acquired were stolen post-disposal and resold, despite being originally slated for d... -
Goodman Advisory Group Invests $1.29 Million in DexCom Amidst Strong Q1 Performance, Revenue Soars 15% to $1.19 Billion
MarketBeat USA Overview Goodman Advisory Group has made a strategic investment of $1.29 million in DexCom, a leading continuous glucose monitoring (CGM) company, following DexCom's strong first-quarter earnings report. The company achiev... -
Senseonics Presents Eversense 365 Real-World Data at ADA Scientific Sessions, Highlights 180-Day Wear for Unmet CGM Needs
Peninsula Fly Fishers USA Overview Senseonics Holdings presented real-world evidence for its Eversense 365 implantable continuous glucose monitoring (CGM) system during the American Diabetes Association (ADA)'s 86th Scientific Sessions. ... -
Medtronic Spins Off Diabetes Business as MiniMed Group, Reshapes Medtech Strategy with AI and Automation Focus
Stock Titan USA Overview Medtronic is strategically realigning its global medical technology business, completing the spin-off of its diabetes operating unit as 'MiniMed Group, Inc.' through an IPO in March 2026. The company is now shapi... -
Zoll Corporation Receives FDA Warning Letter Over Quality Concerns Regarding AccuVent Sensor Malfunction Handling
MedTech Dive USA Overview Zoll Corporation has received a Warning Letter from the U.S. FDA regarding quality concerns, specifically citing inadequate handling of complaints related to malfunctions of its AccuVent sensors used in ventilat... -
Integrating AI with Wearable Sensors: A Future for Advanced Health Monitoring and Early Disease Diagnosis
MDPI (Sensors Journal) Switzerland, International Overview A review paper in MDPI's Sensors journal explores how artificial intelligence (AI) and machine learning (ML) enhance wearable sensors for advanced data analysis, pattern recognit... -
i-SENS’s CareSens Air CGM Secures Belgian Reimbursement, Paving the Way for Expanded European Market Penetration
i-SENS (アジア経済新聞経由) South Korea, ベルギー Overview South Korean medical device firm i-SENS has achieved a critical milestone with its "CareSens Air" continuous glucose monitoring (CGM) device, securing public insurance reimbursem...
